Objectives/hypothesis:
Tumor volume has been demonstrated to play a prognostic role in many head and neck cancers. The purpose of this study was to conduct an institutional review analyzing the correlation between tumor volume and locoregional control of oropharyngeal squamous cell cancer treated with primary radiotherapy.
Study Design:
Retrospective institutional chart analysis.
Methods:
Seventy-nine patients from 1991 to 2005 with primary T1 to T4 oropharyngeal squamous cell carcinoma (base of tongue, n = 31; soft palate, n = 1; tonsils, n = 47) were treated with primary radiotherapy. Tumor volumes were measured from pretreatment computerized tomography scans by two observers. Three-dimensional tumor volumes were calculated using a computer digitizer for each computed tomography slice showing the primary lesion. Survival analysis, using the methods of Kaplan and Meier, was performed to assess whether tumor volume, Tumor, Node, Metastasis classification, tumor stage, or location were associated with locoregional failure.
Results:
Tumor volume did not significantly correlate with locoregional failure (observer 1, P = .6244; observer 2, P = .5612). There was a high interobserver correlation (r = 0.98970). Univariate analysis did, however, demonstrate a significant difference in locoregional failure between T4 tumors and all other T stages (T1 vs. T4, P = .0107; T2 vs. T4, P = .0004; T3 vs. T4, P = .0155). Nodal status, tumor stage, and location did not significantly correlate with locoregional failure rate.
Conclusions:
Tumor volume does not appear to play a significant role in predicting locoregional recurrence for patients with primary squamous cell cancer of the oropharynx treated with primary radiotherapy. However, T4 status was predictive of poor locoregional control.
Citing Articles
Pretreatment Tumor Volume and Tumor Sphericity as Prognostic Factors in Patients with Oral Cavity Squamous Cell Carcinoma: A Prospective Clinical Study in 95 Patients.
Lucchi E, Cercenelli L, Maiolo V, Bortolani B, Marcelli E, Tarsitano A
J Pers Med. 2023; 13(11).
PMID: 38003916
PMC: 10672547.
DOI: 10.3390/jpm13111601.
The Role of Human Chorionic Gonadotropin Beta (hCGβ) in HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma.
Sjoblom A, Carpen T, Stenman U, Jouhi L, Haglund C, Syrjanen S
Cancers (Basel). 2022; 14(12).
PMID: 35740496
PMC: 9221036.
DOI: 10.3390/cancers14122830.
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy.
Adrian G, Carlsson H, Kjellen E, Sjovall J, Zackrisson B, Nilsson P
Radiat Oncol. 2022; 17(1):107.
PMID: 35701827
PMC: 9195357.
DOI: 10.1186/s13014-022-02074-7.
Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis.
Russo E, Accorona R, Iocca O, Costantino A, Malvezzi L, Ferreli F
Cancers (Basel). 2022; 14(10).
PMID: 35626068
PMC: 9139846.
DOI: 10.3390/cancers14102465.
The Epithelial-Mesenchymal Transcription Factor Slug Predicts Survival Benefit of Up-Front Surgery in Head and Neck Cancer.
Riechelmann H, Steinbichler T, Sprung S, Santer M, Runge A, Ganswindt U
Cancers (Basel). 2021; 13(4).
PMID: 33673269
PMC: 7918715.
DOI: 10.3390/cancers13040772.
Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using F-FDG-PET-CT and/or diffusion-weighted MRI.
Greuter M, Schouten C, Castelijns J, de Graaf P, Comans E, Hoekstra O
BMC Cancer. 2017; 17(1):256.
PMID: 28399836
PMC: 5387392.
DOI: 10.1186/s12885-017-3254-0.
CT-based volumetric tumor growth velocity: A novel imaging prognostic indicator in oropharyngeal cancer patients receiving radiotherapy.
Perni S, Mohamed A, Scott J, Enderling H, Garden A, Gunn G
Oral Oncol. 2016; 63:16-22.
PMID: 27938995
PMC: 5157841.
DOI: 10.1016/j.oraloncology.2016.10.022.
Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancer.
Apostolova I, Steffen I, Wedel F, Lougovski A, Marnitz S, Derlin T
Eur Radiol. 2014; 24(9):2077-87.
PMID: 24965509
DOI: 10.1007/s00330-014-3269-8.
Predicting oropharyngeal tumor volume throughout the course of radiation therapy from pretreatment computed tomography data using general linear models.
Yock A, Rao A, Dong L, Beadle B, Garden A, Kudchadker R
Med Phys. 2014; 41(5):051705.
PMID: 24784371
PMC: 5148034.
DOI: 10.1118/1.4870437.
Relationships between Tumor Volume and Lymphatic Metastasis and Prognosis in Early Oral Tongue Cancer.
Joo Y, Hwang S, Sun D, Cho K, Park J, Kim M
Clin Exp Otorhinolaryngol. 2013; 6(4):243-8.
PMID: 24353865
PMC: 3863674.
DOI: 10.3342/ceo.2013.6.4.243.
Volumetric stratification of cT4 stage head and neck cancer.
Studer G, Glanzmann C
Strahlenther Onkol. 2013; 189(10):867-73.
PMID: 24002381
PMC: 3825283.
DOI: 10.1007/s00066-013-0413-3.
Definitive Radiotherapy versus Postoperative Radiotherapy of Patients with Oro- and Hypopharyngeal Cancer: Impact of Prognostic Factors.
Rudat V, Ahmet-Osman S, Schramm O, Dietz A
J Oncol. 2012; 2012:391917.
PMID: 22315594
PMC: 3270431.
DOI: 10.1155/2012/391917.
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.
Lok B, Setton J, Caria N, Romanyshyn J, Wolden S, Zelefsky M
Int J Radiat Oncol Biol Phys. 2011; 82(5):1851-7.
PMID: 21640497
PMC: 4978948.
DOI: 10.1016/j.ijrobp.2011.03.029.
Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.
Chawla S, Kim S, Loevner L, Hwang W, Weinstein G, Chalian A
AJNR Am J Neuroradiol. 2011; 32(4):778-84.
PMID: 21349969
PMC: 7965863.
DOI: 10.3174/ajnr.A2376.
Surgical salvage of cancer of the oropharynx after chemoradiation.
Bumpous J
Curr Oncol Rep. 2009; 11(2):151-5.
PMID: 19216847
DOI: 10.1007/s11912-009-0022-6.